172 related articles for article (PubMed ID: 15024394)
21. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies.
Turner TJ; Mokler DJ; Luebke JI
Neuroscience; 2004; 129(3):703-18. PubMed ID: 15541891
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
23. Effects of protostane-type triterpenoids on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Kang SW; Kim Y; Shin M; Hong M; Seo EK; Kim SH; Nah SY; Bae H
Brain Res; 2010 May; 1331():20-7. PubMed ID: 20307506
[TBL] [Abstract][Full Text] [Related]
24. Effects of urocortin on T-type calcium currents in mouse spermatogenic cells.
Tao J; Wu Y; Chen J; Zhu H; Li S
Biochem Biophys Res Commun; 2005 Apr; 329(2):743-8. PubMed ID: 15737649
[TBL] [Abstract][Full Text] [Related]
25. Ca2+ influx into identified leech neurons induced by 5-hydroxytryptamine.
Dierkes PW; Schlue WR
J Neurobiol; 2005 Jan; 62(1):106-20. PubMed ID: 15452848
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.
Heusler P; Newman-Tancredi A; Loock T; Cussac D
Eur J Pharmacol; 2008 Feb; 581(1-2):37-46. PubMed ID: 18190908
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.
van den Buuse M; Gogos A
J Pharmacol Exp Ther; 2007 Mar; 320(3):1224-36. PubMed ID: 17194799
[TBL] [Abstract][Full Text] [Related]
28. The role of 5-HT3-like receptors in the action of clozapine.
Wang RY; Ashby CR; Edwards E; Zhang JY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():23-6. PubMed ID: 7961566
[TBL] [Abstract][Full Text] [Related]
29. Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Shin JK; Nam JW; Nah SY; Kim SH; Jeong JH; Kim Y; Shin M; Hong M; Seo EK; Bae H
Eur J Pharmacol; 2009 Aug; 615(1-3):27-32. PubMed ID: 19446542
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms mediating serotonin-induced contraction of colonic myocytes.
Xu L; Yu BP; Chen JG; Luo HS
Clin Exp Pharmacol Physiol; 2007; 34(1-2):120-8. PubMed ID: 17201746
[TBL] [Abstract][Full Text] [Related]
31. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
32. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials.
Perez MF; White FJ; Hu XT
J Neurophysiol; 2006 Nov; 96(5):2217-28. PubMed ID: 16885524
[TBL] [Abstract][Full Text] [Related]
34. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function.
Holbrook JD; Gill CH; Zebda N; Spencer JP; Leyland R; Rance KH; Trinh H; Balmer G; Kelly FM; Yusaf SP; Courtenay N; Luck J; Rhodes A; Modha S; Moore SE; Sanger GJ; Gunthorpe MJ
J Neurochem; 2009 Jan; 108(2):384-96. PubMed ID: 19012743
[TBL] [Abstract][Full Text] [Related]
36. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
Cataldi M; Lariccia V; Marzaioli V; Cavaccini A; Curia G; Viggiano D; Canzoniero LM; di Renzo G; Avoli M; Annunziato L
J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
[TBL] [Abstract][Full Text] [Related]
37. Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn.
Fukushima T; Ohtsubo T; Tsuda M; Yanagawa Y; Hori Y
J Neurophysiol; 2009 Sep; 102(3):1459-71. PubMed ID: 19369358
[TBL] [Abstract][Full Text] [Related]
38. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
39. Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells.
Quirk PL; Rao S; Roth BL; Siegel RE
J Neurosci Res; 2004 Aug; 77(4):498-506. PubMed ID: 15264219
[TBL] [Abstract][Full Text] [Related]
40. Serotoninergic modulation of GABAergic synaptic transmission in developing rat CA3 pyramidal neurons.
Choi IS; Cho JH; Kim JT; Park EJ; Lee MG; Shin HI; Choi BJ; Jang IS
J Neurochem; 2007 Dec; 103(6):2342-53. PubMed ID: 17931361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
